Compare Viatris Inc (VTRS) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Viatris Inc vs Zillow Group Inc Class A — how do they compare? Viatris Inc trades at $17.58 (market cap $19.79B), while Zillow Group Inc Class A trades at $31.83 (market cap $7.54B). The key difference: Viatris Inc is far larger — about 2.6× Zillow Group Inc Class A's market cap, and Viatris Inc pays a 2.83% dividend while Zillow Group Inc Class A pays none. Which is the better fit depends on your goals.
| VTRS | ZG | |
|---|---|---|
Market Cap | $19.79B | $7.54B |
Sector | Health | Media |
52-Week High | $17.39 | $86.76 |
52-Week Low | $8.74 | $29.14 |
Enterprise Value | $32.00B | $7.19B |
Dividend Yield | 2.83% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
